Clinical trial
Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed
NCT00034580 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed
- Lead sponsor
- Eli Lilly and Company
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2001
- Completion date
- August 31, 2002
- Enrollment
- 326
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.